The global market for Coronary Heart Disease Diagnostic Imaging Devices was estimated at US$1.9 Billion in 2024 and is projected to reach US$2.6 Billion by 2030, growing at a CAGR of 5.4% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Coronary Heart Disease Diagnostic Imaging Devices market.
Coronary heart disease (CHD) remains a leading cause of mortality worldwide, necessitating advanced diagnostic imaging technologies for early detection and intervention. Imaging devices such as echocardiography, coronary angiography, computed tomography (CT), and magnetic resonance imaging (MRI) play a critical role in assessing coronary artery conditions, detecting blockages, and evaluating heart function. The increasing prevalence of CHD due to sedentary lifestyles, unhealthy diets, and aging populations has spurred demand for more accurate, non-invasive, and real-time imaging solutions. Advancements in artificial intelligence (AI) and machine learning have also enhanced the capabilities of these devices, improving diagnostic precision and patient outcomes. As the need for early CHD detection continues to grow, imaging devices are becoming more sophisticated, with real-time analytics and portable options improving accessibility for diverse patient populations.
What Technological Innovations Are Transforming Coronary Imaging?\
The diagnostic imaging market for coronary heart disease has seen remarkable advancements, with innovations such as high-resolution CT angiography, 3D imaging, and AI-powered diagnostics. These technologies enable physicians to detect coronary artery plaque, stenosis, and myocardial perfusion with greater accuracy and less radiation exposure. The development of hybrid imaging systems that combine CT with positron emission tomography (PET) or single-photon emission computed tomography (SPECT) has further improved diagnostic accuracy. Additionally, the integration of cloud-based data sharing and telecardiology solutions is expanding the reach of advanced imaging services, particularly in remote and underserved regions. As healthcare providers seek more efficient and cost-effective diagnostic methods, these cutting-edge technologies are poised to drive substantial market growth.
How Is the Growing Prevalence of CHD Driving Market Demand?\
The increasing global burden of coronary heart disease has significantly driven demand for advanced diagnostic imaging devices. Factors such as rising obesity rates, hypertension, diabetes, and smoking-related conditions have contributed to an uptick in CHD cases, necessitating regular cardiac assessments. Governments and healthcare organizations worldwide are focusing on preventive healthcare, encouraging routine screenings and early detection through imaging diagnostics. Additionally, the expansion of healthcare infrastructure in developing economies has led to greater accessibility of imaging technologies, bolstering market growth. The push for personalized medicine and precision diagnostics has further increased the adoption of advanced imaging solutions, ensuring targeted and effective CHD treatments.
What Are the Key Growth Drivers for Coronary Imaging Devices?\
The growth in the coronary heart disease diagnostic imaging devices market is driven by several factors, including continuous technological advancements, increasing healthcare expenditure, and rising awareness of heart disease prevention. The integration of AI-powered analytics in imaging devices has enhanced diagnostic accuracy, enabling faster and more efficient disease detection. Furthermore, the increasing demand for minimally invasive and non-invasive imaging solutions has spurred innovation in computed tomography angiography (CTA) and MRI technologies. The expansion of telemedicine and remote monitoring has also created opportunities for mobile and portable imaging solutions, ensuring broader accessibility. As healthcare policies emphasize early detection and preventive cardiology, the market for coronary imaging devices is expected to witness sustained growth.
Segments: Modality (Computed Tomography, X-Ray, Ultrasound, Magnetic Resonance Imaging, Nuclear Medicine); Application (Arrhythmia Application, Heart Attack Application, Heart Failure Application, Congenital Heart Conditions Application, Other Applications); End-Use (Hospitals End-Use, Diagnostic Imaging Centers End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
Global Coronary Heart Disease Diagnostic Imaging Devices Market - Key Trends & Drivers Summarized
Why Are Diagnostic Imaging Devices Crucial for Coronary Heart Disease Detection?\Coronary heart disease (CHD) remains a leading cause of mortality worldwide, necessitating advanced diagnostic imaging technologies for early detection and intervention. Imaging devices such as echocardiography, coronary angiography, computed tomography (CT), and magnetic resonance imaging (MRI) play a critical role in assessing coronary artery conditions, detecting blockages, and evaluating heart function. The increasing prevalence of CHD due to sedentary lifestyles, unhealthy diets, and aging populations has spurred demand for more accurate, non-invasive, and real-time imaging solutions. Advancements in artificial intelligence (AI) and machine learning have also enhanced the capabilities of these devices, improving diagnostic precision and patient outcomes. As the need for early CHD detection continues to grow, imaging devices are becoming more sophisticated, with real-time analytics and portable options improving accessibility for diverse patient populations.
What Technological Innovations Are Transforming Coronary Imaging?\
The diagnostic imaging market for coronary heart disease has seen remarkable advancements, with innovations such as high-resolution CT angiography, 3D imaging, and AI-powered diagnostics. These technologies enable physicians to detect coronary artery plaque, stenosis, and myocardial perfusion with greater accuracy and less radiation exposure. The development of hybrid imaging systems that combine CT with positron emission tomography (PET) or single-photon emission computed tomography (SPECT) has further improved diagnostic accuracy. Additionally, the integration of cloud-based data sharing and telecardiology solutions is expanding the reach of advanced imaging services, particularly in remote and underserved regions. As healthcare providers seek more efficient and cost-effective diagnostic methods, these cutting-edge technologies are poised to drive substantial market growth.
How Is the Growing Prevalence of CHD Driving Market Demand?\
The increasing global burden of coronary heart disease has significantly driven demand for advanced diagnostic imaging devices. Factors such as rising obesity rates, hypertension, diabetes, and smoking-related conditions have contributed to an uptick in CHD cases, necessitating regular cardiac assessments. Governments and healthcare organizations worldwide are focusing on preventive healthcare, encouraging routine screenings and early detection through imaging diagnostics. Additionally, the expansion of healthcare infrastructure in developing economies has led to greater accessibility of imaging technologies, bolstering market growth. The push for personalized medicine and precision diagnostics has further increased the adoption of advanced imaging solutions, ensuring targeted and effective CHD treatments.
What Are the Key Growth Drivers for Coronary Imaging Devices?\
The growth in the coronary heart disease diagnostic imaging devices market is driven by several factors, including continuous technological advancements, increasing healthcare expenditure, and rising awareness of heart disease prevention. The integration of AI-powered analytics in imaging devices has enhanced diagnostic accuracy, enabling faster and more efficient disease detection. Furthermore, the increasing demand for minimally invasive and non-invasive imaging solutions has spurred innovation in computed tomography angiography (CTA) and MRI technologies. The expansion of telemedicine and remote monitoring has also created opportunities for mobile and portable imaging solutions, ensuring broader accessibility. As healthcare policies emphasize early detection and preventive cardiology, the market for coronary imaging devices is expected to witness sustained growth.
Report Scope
The report analyzes the Coronary Heart Disease Diagnostic Imaging Devices market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.Segments: Modality (Computed Tomography, X-Ray, Ultrasound, Magnetic Resonance Imaging, Nuclear Medicine); Application (Arrhythmia Application, Heart Attack Application, Heart Failure Application, Congenital Heart Conditions Application, Other Applications); End-Use (Hospitals End-Use, Diagnostic Imaging Centers End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Computed Tomography segment, which is expected to reach US$1.2 Billion by 2030 with a CAGR of a 6.5%. The X-Ray segment is also set to grow at 3.3% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $507.2 Million in 2024, and China, forecasted to grow at an impressive 8.7% CAGR to reach $516.5 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Coronary Heart Disease Diagnostic Imaging Devices Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Coronary Heart Disease Diagnostic Imaging Devices Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Coronary Heart Disease Diagnostic Imaging Devices Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Analogic Corporation, Boston Scientific Corporation, Bracco Imaging S.p.A., Canon Inc., Carestream Health and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 44 Featured):
- Analogic Corporation
- Boston Scientific Corporation
- Bracco Imaging S.p.A.
- Canon Inc.
- Carestream Health
- CHISON Medical Technologies Co., Ltd.
- Esaote S.p.A.
- FUJIFILM Holdings Corporation
- GE HealthCare Technologies Inc.
- HeartFlow, Inc.
- Hitachi Medical Corporation
- Hologic, Inc.
- Koninklijke Philips N.V.
- Neusoft Corporation
- Positron Corporation
- Samsung Electronics Co., Ltd.
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Shimadzu Corporation
- Siemens Healthineers AG
- Ziehm Imaging GmbH
Tariff Impact Analysis: Key Insights for 2025
Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
What’s Included in This Edition:
- Tariff-adjusted market forecasts by region and segment
- Analysis of cost and supply chain implications by sourcing and trade exposure
- Strategic insights into geographic shifts
Buyers receive a free July 2025 update with:
- Finalized tariff impacts and new trade agreement effects
- Updated projections reflecting global sourcing and cost shifts
- Expanded country-specific coverage across the industry
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Analogic Corporation
- Boston Scientific Corporation
- Bracco Imaging S.p.A.
- Canon Inc.
- Carestream Health
- CHISON Medical Technologies Co., Ltd.
- Esaote S.p.A.
- FUJIFILM Holdings Corporation
- GE HealthCare Technologies Inc.
- HeartFlow, Inc.
- Hitachi Medical Corporation
- Hologic, Inc.
- Koninklijke Philips N.V.
- Neusoft Corporation
- Positron Corporation
- Samsung Electronics Co., Ltd.
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Shimadzu Corporation
- Siemens Healthineers AG
- Ziehm Imaging GmbH
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 392 |
| Published | April 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 1.9 Billion |
| Forecasted Market Value ( USD | $ 2.6 Billion |
| Compound Annual Growth Rate | 5.4% |
| Regions Covered | Global |
